Background: South Carolina (SC) is located in the “buckle” of the stroke belt with one of the highest stroke death rates in the country. In 2010, SC had 66 acute care hospitals caring for strokes, nine of which were certified primary stroke centers (PSC). The rate of intravenous tissue plasminogen activator (IV-tPA) use and its correlates have not been investigated in the state. Objectives: To study the rate of IV-tPA use and its correlates using the statewide hospital discharge records stored at SC Department of Health and Environmental Control (DHEC), for the calendar year 2010. Methods: A retrospective analysis was conducted of the statewide hospital discharge records stored at SC DHEC, for the calendar year 2010. Patients with a discharge diagnosis of ischemic stroke were included in the analysis. Variables considered included patient demographics, insurance status, location/type of destination hospital, and treatment with IV-tPA. Results: In the calendar year 2010, 10,377 hospitalized patients in SC were assigned a primary discharge diagnosis of ischemic stroke. Of these, 4.2% (442) were treated with IV-tPA. Those who were treated with IV-tPA were younger (mean age ± standard deviation=66.7 ± 14.4, p=0.002) compared with those who did not receive IV-tPA (68.8±13.6). Patients treated at a PSC (49% of all ischemic stroke patients) were more likely to receive IV-tPA (Odds Ratio or OR 4.0, 95% CI 3.2-5.0).Patients treated in hospitals located in urban counties were more likely to receive IV-tPA compared to those treated in rural counties (OR 1.3, 95% CI 1.1-5.3). On multivariate logistic regression analysis, patients treated at a PSC (Adjusted OR 2.2, 95% CI 1.9-2.5) and those treated in urban counties (Adjusted OR 1.4, 95% CI 1.1-1.8) independently increased the likelihood of receiving IV-tPA. Gender, race and insurance status did not significantly change the likelihood of receiving IV-tPA. Conclusions: Younger stroke patients, treatment in a PSC and hospitals located in an urban county increased the likelihood of receiving IV-tPA. Increasing community awareness of PSCs, their location and designation may increase the rate of IV-tPA use.
Introduction: In acute ischemic stroke (AIS), intravenous tissue plasminogen activator (IV TPA), if administered appropriately can be beneficial; however, with stroke misdiagnosis, it can expose patients to unnecessary bleeding risks. Thus, accurate diagnosis is critical. Brain Magnetic Resonance Imaging (MRI) is sensitive to detect AIS; however, a complete exam may consume 30-45 minutes. At the University of South Carolina Palmetto Health Richland Stroke Center, an ultra-rapid, 10 minute MRI called the Brain Attack Team MRI (BAT MRI) was designed to accurately and expeditiously diagnose AIS. Hypothesis: BAT MRI is a useful clinical tool to select or exclude patients for IV TPA who present acutely with stroke-like symptoms. Clinical correlates are not an effective substitution for BAT MRI to confirm AIS. Methods: In an ongoing study, conducted in 2010-11, 31 consecutive patients were identified who presented <4.5 hours from symptom onset and received a BAT MRI. They were 43-90 years in age; 48.4% White, 48.4% African American, and 3.2% unknown. BAT MRIs included diffusion weighted imaging, T2 gradient echo, T2 axial, and FLAIR sequences. The algorithm for BAT MRI use is shown in Figure 1. BAT MRIs were evaluated for ischemia, hemorrhage and other central nervous system (CNS) pathologies. Stroke risk factor correlates of abnormal BAT MRIs were assessed using t-test for continuous variables and Fisher's Exact Test for categorical variables. Results: Of the 31 BAT MRIs, 13 were read as abnormal (11-acute ischemia, 1-hemorrhage, 1-ischemia with hemorrhage). The hemorrhage was in the pons on BAT MRI and was not detected by CT. This finding excluded using IV TPA in this patient. Two cases where BAT MRI demonstrated AIS met NINDS/ECASS-III criteria and received IV TPA. Of the 18, in whom BAT MRI was read as normal, 9 had a discharge diagnosis of TIA, 2 MRI negative strokes, 3 conversion disorders, 1 CNS neoplasm, 1 respiratory failure and 1 peripheral vertigo. Stroke risk factor analysis yielded no significant correlation between BAT MRI findings and gender, race, prior stroke/TIA, coronary artery disease, diabetes, hyperlipidemia, hypertension, or smoking. Patients with AIS on BAT MRI were older (68.2 ± 17.5) than those without (58.6 ± 9.7); although, it bordered statistical significance (p=0.08). Atrial fibrillation correlated with AIS on BAT MRI (p=0.02). Conclusion: In patients with AIS-like symptoms, BAT MRI may be used to confirm AIS, exclude stroke mimics and assess candidacy for IV TPA. Atrial fibrillation correlated with AIS on BAT MRI; therefore, these patients may be more likely to be IV TPA candidates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.